Respirerx Pharmaceuticals, Inc.

• Cover
  • Document and Entity Information
• Financial Statements
  • Consolidated Balance Sheets
  • Consolidated Balance Sheets (Parenthetical)
  • Consolidated Statements of Operations
  • Consolidated Statements of Operations (Parenthetical)
  • Consolidated Statement of Stockholders' Deficiency
  • Consolidated Statement of Stockholders' Deficiency (Parenthetical)
  • Consolidated Statements of Cash Flows
  • Consolidated Statements of Cash Flows (Parenthetical)
• Notes to Financial Statements
  • Organization and Basis of Presentation
  • Business
  • Summary of Significant Accounting Policies
  • Notes Payable
  • Settlement and Payment Agreements
  • Stockholders' Deficiency
  • Income Taxes
  • Related Party Transactions
  • Commitments and Contingencies
  • Subsequent Events
• Accounting Policies
  • Summary of Significant Accounting Policies (Policies)
• Notes Tables
  • Summary of Significant Accounting Policies (Tables)
  • Notes Payable (Tables)
  • Settlement and Payment Agreements (Tables)
  • Stockholders' Deficiency (Tables)
  • Income Taxes (Tables)
  • Commitments and Contingencies (Tables)
• Notes Details
  • Organization and Basis of Presentation (Details Narrative)
  • Business (Details Narrative)
  • Summary of Significant Accounting Policies (Details Narrative)
  • Summary of Significant Accounting Policies - Summary of Fair Value of Warrants Estimated Using Black-Scholes Pricing Model With Valuation Assumptions (Details)
  • Summary of Significant Accounting Policies - Summary of Fair Value of Option Estimated Using Black-Scholes Pricing Model with Valuation Assumptions (Details)
  • Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)
  • Notes Payable (Details Narrative)
  • Notes Payable - Schedule of Notes Payable (Details)
  • Notes Payable - Summary of Note Payable to Related Party (Details)
  • Settlement and Payment Agreements (Details Narrative)
  • Settlement and Payment Agreements - Summary of Result of the Forgiveness and NQSO Grant Transactions (Details)
  • Stockholders' Deficiency (Details Narrative)
  • Stockholders' Deficiency - Schedule of Warrants Activity (Details)
  • Stockholders' Deficiency - Schedule of Exercise Prices of Common Stock Warrants Outstanding and Exercisable (Details)
  • Stockholders' Deficiency - Schedule of Stock Options Activity (Details)
  • Stockholders' Deficiency - Schedule of Exercise Prices of Common Stock Options Outstanding and Exercisable (Details)
  • Income Taxes (Details Narrative)
  • Income Taxes - Schedule of Deferred Tax Assets (Details)
  • Income Taxes - Reconciliation of Income Tax Rate Federal Statutory Rate and Effective Tax Rate (Details)
  • Related Party Transactions (Details Narrative)
  • Commitments and Contingencies (Details Narrative)
  • Commitments and Contingencies - Schedule of Principal Cash Obligations and Commitments (Details)
  • Subsequent Events (Details Narrative)
• All Reports

Filing Date: 04-17-2018 Form Type: Form 10-K Description: Annual report